CervoMed (CRVO) Amortizatization of Intangibles (2015 - 2026)
CervoMed (CRVO) posted Amortizatization of Intangibles of $70104.0 for Q1 2026, down 52.0% sequentially from $146058.0 in Q4 2025, and down 72.16% YoY from $251828.0 in Q1 2025.
CervoMed (CRVO) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
CervoMed has reported Amortizatization of Intangibles for 7 years, with the latest figure at $70104.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 72.16% year-over-year to $70104.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $672353.0 (down 39.98% YoY) and the FY2025 annual result came in at $854077.0, down 29.13% from the prior year.
- Amortizatization of Intangibles declined to $70104.0 in Q1 2026 per CRVO's latest filing, from $146058.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $483990.0 in Q3 2024 and troughed at $70104.0 in Q1 2026.
- A 3-year average of $255881.4 and a median of $234666.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles tumbled 54.23% in 2025, then plunged 72.16% in 2026.
- Over 3 years, Amortizatization of Intangibles stood at $382999.0 in 2024, then slumped by 61.86% to $146058.0 in 2025, then slumped by 52.0% to $70104.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $70104.0, $146058.0, and $221525.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | 19,139.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19,139.00 |
| Jun 30, 2026 | 19,139.00 |
| Mar 31, 2026 | 70,104.00 |
| Mar 31, 2026 | 70,104.00 |
| Dec 31, 2025 | 146,058.00 |
| Dec 31, 2025 | 146,058.00 |
| Sep 30, 2025 | 221,525.00 |
| Sep 30, 2025 | 221,525.00 |
| Jun 30, 2025 | 234,666.00 |
| Jun 30, 2025 | 234,666.00 |
| Mar 31, 2025 | 251,828.00 |
| Mar 31, 2025 | 251,828.00 |
| Dec 31, 2024 | 382,999.00 |
| Dec 31, 2024 | 382,999.00 |
| Sep 30, 2024 | 483,990.00 |
| Sep 30, 2024 | 483,990.00 |
| Mar 31, 2018 | 1,356.00 |
| Mar 31, 2018 | 1,356.00 |
| Dec 31, 2017 | 21,550.00 |
| Dec 31, 2017 | 21,550.00 |